公司资料

OKYO Pharma 股价、新闻与催化剂

股票代码:: OKYO
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股票表现

1.32 USD (-0.75%)

收盘价

最后更新: 2026年9月17日

89.2M USD

市值

股价为何变动

截至 2026年9月17日，OKYO 下跌 0.75%，收于 $1.32。当前新闻监测窗口内未发现新的同公司新闻。

公司概览

业务概览

OKYO Pharma is a biotechnology company focused on inflammation, pain, and ophthalmology-related disease biology. Its programs are aimed at serious conditions where immune modulation and localized therapy matter.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, OKYO sits in specialty biotechnology.

商业模式特征

The company depends on clinical data, target validation, and the ability to create a differentiated inflammation and eye-care story.

生物医药行业定位

OKYO is a catalyst-sensitive specialty name whose stock is driven by early-stage progress.

未来催化剂

OKYO’s catalysts are its ophthalmic-inflammatory pipeline and any update that shows the company can still build a real eye-disease story. The company remains early and data-dependent.